Cargando…
Improving the metabolic fidelity of cancer models with a physiological cell culture medium
Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314821/ https://www.ncbi.nlm.nih.gov/pubmed/30613774 http://dx.doi.org/10.1126/sciadv.aau7314 |
_version_ | 1783384166638813184 |
---|---|
author | Vande Voorde, Johan Ackermann, Tobias Pfetzer, Nadja Sumpton, David Mackay, Gillian Kalna, Gabriela Nixon, Colin Blyth, Karen Gottlieb, Eyal Tardito, Saverio |
author_facet | Vande Voorde, Johan Ackermann, Tobias Pfetzer, Nadja Sumpton, David Mackay, Gillian Kalna, Gabriela Nixon, Colin Blyth, Karen Gottlieb, Eyal Tardito, Saverio |
author_sort | Vande Voorde, Johan |
collection | PubMed |
description | Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabolic artifacts on cancer cells. Their supraphysiological concentrations of pyruvate stabilize hypoxia-inducible factor 1α in normoxia, thereby inducing a pseudohypoxic transcriptional program. In addition, their arginine concentrations reverse the urea cycle reaction catalyzed by argininosuccinate lyase, an effect not observed in vivo, and prevented by Plasmax in vitro. The capacity of cancer cells to form colonies in commercial media was impaired by lipid peroxidation and ferroptosis and was rescued by selenium present in Plasmax. Last, an untargeted metabolic comparison revealed that breast cancer spheroids grown in Plasmax approximate the metabolic profile of mammary tumors better. In conclusion, a physiological medium improves the metabolic fidelity and biological relevance of in vitro cancer models. |
format | Online Article Text |
id | pubmed-6314821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63148212019-01-04 Improving the metabolic fidelity of cancer models with a physiological cell culture medium Vande Voorde, Johan Ackermann, Tobias Pfetzer, Nadja Sumpton, David Mackay, Gillian Kalna, Gabriela Nixon, Colin Blyth, Karen Gottlieb, Eyal Tardito, Saverio Sci Adv Research Articles Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabolic artifacts on cancer cells. Their supraphysiological concentrations of pyruvate stabilize hypoxia-inducible factor 1α in normoxia, thereby inducing a pseudohypoxic transcriptional program. In addition, their arginine concentrations reverse the urea cycle reaction catalyzed by argininosuccinate lyase, an effect not observed in vivo, and prevented by Plasmax in vitro. The capacity of cancer cells to form colonies in commercial media was impaired by lipid peroxidation and ferroptosis and was rescued by selenium present in Plasmax. Last, an untargeted metabolic comparison revealed that breast cancer spheroids grown in Plasmax approximate the metabolic profile of mammary tumors better. In conclusion, a physiological medium improves the metabolic fidelity and biological relevance of in vitro cancer models. American Association for the Advancement of Science 2019-01-02 /pmc/articles/PMC6314821/ /pubmed/30613774 http://dx.doi.org/10.1126/sciadv.aau7314 Text en Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Vande Voorde, Johan Ackermann, Tobias Pfetzer, Nadja Sumpton, David Mackay, Gillian Kalna, Gabriela Nixon, Colin Blyth, Karen Gottlieb, Eyal Tardito, Saverio Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
title | Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
title_full | Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
title_fullStr | Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
title_full_unstemmed | Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
title_short | Improving the metabolic fidelity of cancer models with a physiological cell culture medium |
title_sort | improving the metabolic fidelity of cancer models with a physiological cell culture medium |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314821/ https://www.ncbi.nlm.nih.gov/pubmed/30613774 http://dx.doi.org/10.1126/sciadv.aau7314 |
work_keys_str_mv | AT vandevoordejohan improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT ackermanntobias improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT pfetzernadja improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT sumptondavid improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT mackaygillian improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT kalnagabriela improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT nixoncolin improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT blythkaren improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT gottliebeyal improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium AT tarditosaverio improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium |